Project Grant G2640084

This $3,750,000 Rural Communities Opioid Response Program-Impact (RCORP-IMPACT) award, funded by the U.S. Department of Health and Human Services (CFDA 93.155 Rural Health Research Centers), will establish the ATLAS Center in southeast Kentucky to enhance substance use disorder (SUD) treatment and recovery services. Key objectives include expanding access to medication for opioid use disorder (MOUD) and evidence-based, trauma-informed counseling, increasing certified peer support specialist...

This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...

The Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $3,000,000 Rural Health Research Centers (CFDA 93.155) program grant to Core Treatment Services, Inc. in Manitowoc, Wisconsin. The grant, effective September 1, 2024 through August 31, 2028, will fund the "Rural Communities Opioid Response Program-IMPACT" project. This project aims to address the opioid epidemic in five rural Wisconsin counties by providing comprehensive treatment,...

This Project Grant award of $251,006 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to assess the potential of bedside measures of cerebral physiology to screen neonates with prenatal opioid exposure (POE) and/or neonatal opioid withdrawal symptoms (NOWS). The researchers at Indiana University will use a hybrid device combining frequency-domain near-infrared spectroscopy (FD-NIRS) and diffuse correlation...

The U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $1,500,000 Project Grant under the Rural Health Research Centers (CFDA 93.155) program to Casa-Trinity Inc., a non-profit organization in Geneseo, NY. The grant, awarded on September 1, 2024, will fund the "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT" initiative over a 4-year period ending on August 31, 2028. The project aims to address the critical opioid epidemic in...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project entitled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome." The $180,059 award, effective August 1, 2024, will fund a 5-year longitudinal study to assess the independent and moderating effects of positive childhood experiences (PCEs) and adverse childhood experiences...

The Nevada State Opioid Response (SOR) Program, funded by a $83,174,470 federal Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance, aims to combat the opioid and stimulant crisis in Nevada. Key products and services delivered through this grant include: Expanding access to evidence-based opioid and stimulant use disorder treatment, with plans to...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

The U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) awarded a $1,500,000 Project Grant under the Rural Health Research Centers (CFDA 93.155) program to Rural Health Inc., a federally qualified health center serving southern Illinois. The 4-year grant, effective September 1, 2024, will expand access to medication-assisted treatment and substance use disorder recovery services in the rural Union, Johnson, and Massac counties. Key objectives include...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 Drug Use and Addiction Research Programs, provides $3,503,736 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county juvenile court systems. The project aims to collaboratively co-design the prevention strategy and an implementation...